TransUnion is in a choppy, range-bound consolidation with a distinctly negative longer-term tilt: the stock is down 5.39% over the past year and 11.10% year-to-date, a stark underperformance versus the S&P 500's +15.53% one-year return (relative strength of -20.92%). At $74.08, the shares sit at roughly 46.5% of the 52-week range of $60.96 to $89.12 — below the midpoint and closer to the lower quartile than the highs — which signals neither a clean momentum breakout nor a deep-value falling knife, but rather a market that has repeatedly faded rallies. The stock's max drawdown of -34.24% over the trailing period underscores how punishing the de-rating has been for holders. Short-term momentum is stabilizing but not yet constructive: the 1-month change of -0.78% and 3-month change of -7.23% both lag the S&P 500 (+1.22% and +2.69%, respectively), producing relative strength readings of -2.00 (1M) and -9.92 (3M). The most notable feature of the tape is the sharp two-session surge on October 15-16, when the stock jumped from $66.94 to $74.12 (+10.7%) on elevated volume of 3.52 million shares — a violent mean-reversion move off the late-September trough of $61.12 that suggests buyers are defending the low-$60s. That bounce conflicts with the still-negative 6-month (-5.33%) and YTD (-11.10%) trends, and until the stock reclaims its intermediate moving averages, it reads more as a relief rally than a confirmed reversal. Key technical levels are well defined: support sits at the 52-week low of $60.96 (with the September closing low of $61.12 as the practical floor), while resistance is the 52-week high of $89.12, with the August highs around $85.67 as the first meaningful hurdle. A decisive break above $85-89 would signal a trend change and likely force short covering — the short ratio of 4.51 days-to-cover indicates a meaningful bearish position that could amplify upside — whereas a breakdown below $61 would confirm the downtrend and open fresh lows. With a beta of 1.576, TransUnion is roughly 58% more volatile than the market, meaning position sizing should account for amplified drawdowns; the recent 10% two-day move is a textbook illustration of that elevated volatility.

Revenue momentum has inflected decisively positive: Q2 2026 revenue of $1.3096 billion grew 14.9% year over year versus $1.1398 billion in Q2 2025, and the sequential progression from $1.2457 billion in Q1 2026 and $1.1714 billion in Q4 2025 confirms an accelerating trajectory rather than a one-quarter blip. The segment mix shows U.S. Markets at $992.7 million and International at $320.8 million, meaning the domestic franchise still drives roughly 76% of revenue while international (bolstered by the Buró de Crédito acquisition) provides the faster-growing, diversifying leg. Notably, the 14.9% growth rate is well above the ~5-7% organic pace typical of the bureau oligopoly, implying a combination of pricing, new-product penetration, and inorganic contribution — a mix that supports the bull case but also raises the bar for sustainability. Profitability is solid but noisy: Q2 2026 net income was $252.9 million (a 19.3% net margin) on a 58.4% gross margin, and operating income of $418.5 million represented a 31.96% operating margin — a marked improvement from the 17.4% operating margin in Q4 2025 and 18.2% in Q3 2025. The quarterly EPS path ($0.75 in Q2 2026, $2.06 in Q1 2026, $0.52 in Q4 2025) is distorted by one-time items such as the $183.3 million other-income gain in Q1 and a $217 million other-expense drag in Q2, so investors should focus on the underlying operating margin trend, which is clearly expanding. Gross margin has been remarkably stable in the 58-59% band across the last four quarters, consistent with the high-incremental-margin economics of a data utility. Balance-sheet health is adequate but levered: debt-to-equity stands at 1.16, the current ratio is a comfortable 1.75, and TTM free cash flow is $787.9 million against a $16.67 billion market cap (an FCF yield of roughly 4.7%). Cash generation is real — Q2 2026 operating cash flow of $374.9 million less $69.2 million of capex produced $305.7 million of FCF — but the company is actively deploying capital into acquisitions ($578.6 million in Q1 2026), buybacks ($83 million in Q2), and a modest dividend (0.54% yield), while ROE of 10.26% and ROA of 4.94% reflect the drag from a leveraged, acquisition-heavy capital structure rather than weak underlying economics.